{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:34:06Z","timestamp":1761863646835,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T00:00:00Z","timestamp":1511136000000},"content-version":"vor","delay-in-days":203,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ahj.2017.02.015","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T01:15:49Z","timestamp":1487639749000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial"],"prefix":"10.1016","volume":"187","author":[{"given":"Miguel E.","family":"Lemmert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Oldroyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Barragan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Lesiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeny","family":"Merkulov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Daemen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Witberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert-Jan","family":"van Geuns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2017.02.015_bb0005","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/01.CIR.91.9.2325","article-title":"Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience","volume":"91","author":"Caracciolo","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.02.015_bb0010","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/CIRCULATIONAHA.109.899211","volume":"121","author":"Morice","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.02.015_bb0015","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1100452","article-title":"Randomized trial of stents versus bypass surgery for left main coronary artery disease","volume":"364","author":"Park","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.02.015_bb0020","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jcin.2012.05.002","volume":"5","author":"Kim","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2017.02.015_bb0025","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.113.006689","article-title":"Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial","volume":"129","author":"Morice","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.02.015_bb0030","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.jacc.2015.03.033","article-title":"Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT study","volume":"65","author":"Ahn","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.015_bb0035","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejcts.2010.08.019","article-title":"Guidelines on myocardial revascularization","volume":"38","author":"Task Force on Myocardial Revascularization of the European Society of C","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ahj.2017.02.015_bb0040","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Authors\/Task Force m","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.02.015_bb0045","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.015_bb0050","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/S0140-6736(16)32052-9","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial","volume":"388","author":"Makikallio","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.02.015_bb0055","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.015_bb0060","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1610227","article-title":"Everolimus-eluting stents or bypass surgery for left main coronary artery disease","volume":"375","author":"Stone","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.02.015_bb0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11883-014-0485-2","article-title":"Drug-eluting stents: the past, present, and future","volume":"17","author":"Katz","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ahj.2017.02.015_bb0070","first-page":"35","article-title":"The evolution of coronary stents: a brief review","volume":"30","author":"Simard","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2017.02.015_bb0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12325-010-0022-9","article-title":"The platinum chromium element stent platform: from alloy, to design, to clinical practice","volume":"27","author":"Menown","year":"2010","journal-title":"Adv Ther"},{"key":"10.1016\/j.ahj.2017.02.015_bb0080","first-page":"149","article-title":"A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease","volume":"7","author":"Bennett","year":"2013","journal-title":"Biologics"},{"key":"10.1016\/j.ahj.2017.02.015_bb0085","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.02.015_bb0090","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2011.12.016","article-title":"Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent","volume":"59","author":"Meredith","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.015_bb0095","doi-asserted-by":"crossref","first-page":"308","DOI":"10.4244\/EIJV9I3A52","article-title":"Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent","volume":"9","author":"Meredith","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2017.02.015_bb0100","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372","article-title":"Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II randomized trial","volume":"8","author":"Kereiakes","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2017.02.015_bb0105","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4244\/EIJV8I11A200","article-title":"Maximal expansion capacity with current DES platforms: a critical factor for stent selection in the treatment of left main bifurcations?","volume":"8","author":"Foin","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2017.02.015_bb0110","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/eurheartj\/ehs460","article-title":"Should duration of dual antiplatelet therapy depend on the type and\/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)","volume":"34","author":"Valgimigli","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.02.015_bb0115","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.02.015_bb0120","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2017.02.015_bb0125","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2014.12.046","article-title":"Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.015_bb0130","doi-asserted-by":"crossref","first-page":"h1618","DOI":"10.1136\/bmj.h1618","article-title":"Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials","volume":"350","author":"Navarese","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2017.02.015_bb0135","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.02.015_bb0140","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.02.015_bb0145","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.02.015_bb0150","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/eurheartj\/ehq117","volume":"31","author":"Lip","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.02.015_bb0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCINTERVENTIONS.108.799494","article-title":"Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis","volume":"2","author":"Park","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2017.02.015_bb0160","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcin.2013.09.014","article-title":"Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries","volume":"7","author":"de la Torre Hernandez","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2017.02.015_bb0165","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1093\/eurheartj\/ehs095","article-title":"Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures","volume":"33","author":"Prati","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.02.015_bb1170","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI)","volume":"62","author":"Moussa","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.015_bb0170","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.02.015_bb0175","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"key":"10.1016\/j.ahj.2017.02.015_bb0180","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jcin.2010.03.014","article-title":"5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience","volume":"3","author":"Chieffo","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2017.02.015_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jacc.2010.04.004","volume":"56","author":"Park","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.015_bb0190","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jacc.2009.01.035","article-title":"Stenting L-MI and angiographic results: drug-eluting stents for unprotected coronary left main lesions study I. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease","volume":"53","author":"Mehilli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.02.015_bb0195","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.jacc.2013.07.044","article-title":"Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease","volume":"62","author":"Mehilli","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317300509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317300509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:58:26Z","timestamp":1757570306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870317300509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":40,"alternative-id":["S0002870317300509"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.02.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}